Predicators of clinical response in patients with high risk acute myeloid leukemia receiving treatment with the histone deacetylase inhibitor sodium valproate

Charles Craddock, Charlotte Bradbury, S Narayanan, A Rye, Supratik Basu, A MacWhannell, A Sawers, M Cook, M Griffiths, D Grimwade, Christopher Bunce, B Turner

Research output: Contribution to conference (unpublished)Abstract

Original languageEnglish
Publication statusPublished - 1 Jan 2005

Cite this